Delivery Order SPE2DB24D2003-SPE2DB25FXHH8
Award Date
5/2/25
Potential Completion Date
5/5/25
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,613.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a performance period through May 5, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,276.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of a specific medication, ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, with a performance period through April 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,123.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a performance period through May 2025. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,468.31 firm fixed-price delivery order is for the supply of the medication ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, with a period of performance through April 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,857.73, is a delivery order for the supply of the medication ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price, non-set-aside award with a completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $9,606.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 18, 2025 and is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,982.20, is a delivery order for the supply of the drug ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of April 22, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
The federal contract award, valued at $1,525.20, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order contract with a firm fixed price pricing type. The contract covers the procurement of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical supplies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $17,249.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a period of performance through March 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,084.47 firm fixed-price delivery order contract is for the supply of a specific medication, ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of October 25, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...